NCT06873321View on ClinicalTrials.gov

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 24, 2024

Primary Completion Date

July 20, 2025

Study Completion Date

July 30, 2025

Conditions
Peripheral Arterial DiseaseVenous ThormboembolismCardiovascular DiseasesVascular Surgery Patient with PAD / Carotid Stenosis
Interventions
DRUG

rivaroxaban 2.5 mg bid + aspirin 100 mg

rivaroxaban 2.5 mg bid + aspirin

DRUG

clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures

comparator

Trial Locations (1)

50740-900

RECRUITING

Hospital das Clínicas, Federal University of Pernambuco, Pernambuco

All Listed Sponsors
lead

Science Valley Research Institute

OTHER